I've been telling you all that it was a bioweapon that was designed to kill Aryans and be harmless to ashkenazi jews for the last 2-3 years.
Read this study or at least look at the graphics: https://pubmed.ncbi.nlm.nih.gov/32844124/
Also, that lady got so many facts wrong she should just STFU. She's basically well poisoning by fucking it up so badly.
It's not "zero" in ashkenazi jews, but it is a far lower binding affinity than other races, making them less vulnerable. Europeans and South Asians (not "non-african blacks as she says) are most vulnerable.
Furthermore, the study she references makes zero references to the Amish, but she claims it does. I linked it, see for yourself in the full text.
Intentionally muddying the waters to make any real criticism seem aligned w crackpots like her.
Please try to provide an archive link with .gov ones.
Archive #1 (archive.ph)
Archive #2 (web.archive.org)
That's not the full text archive link. It's this: https://archive.is/ZtgyZ
This is a different archived link.
Archive #1 is the archive of the link you provided in your initial comment.
We found that the distribution of deleterious variants in ACE2 differs among 9 populations in gnomAD (v3).
Specifically, 39% (24/61) and 54% (33/61) of deleterious variants in ACE2 occur in African/African-American (AFR) and Non-Finnish European (EUR) populations, respectively (Fig. 1b). Prevalence of deleterious variants among Latino/Admixed American (AMR), East Asian (EAS), Finnish (FIN), and South Asian (SAS) populations is 2–10%, while Amish (AMI) and Ashkenazi Jewish (ASJ) populations do not appear to carry such variants in ACE2 coding regions(Fig. 1b). Specifically, several variants, including p.Met383Thr, p.Pro389His, and p.Asp427Tyr, have been reported to slightly inhibit the interaction between ACE2 and the spike protein of SARS-CoV-1 [10], which caused the first global SARSCoV-1 outbreak. Only AFR populations carry p.Met383Thr and p.Asp427Tyr variants, with allele frequencies of 0.003% and 0.01%, respectively (Fig. 1b). The p.Pro389His only occurs in the AMR populations, with an allele frequency of 0.015%. The p.Arg514Gly is a low allele frequency (0.003%) variant in AFR populations and is also somatically mutated in colon cancers and Hou et al. BMC Medicine (2020)
